Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fabiana Zingone and Andrea Buda.
Fabiana Zingone
Connection Strength
0.899
Andrea Buda
  1. Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing? J Crohns Colitis. 2020 12 02; 14(12):1785.
    View in: PubMed
    Score: 0.229
  2. Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice. Dig Liver Dis. 2020 11; 52(11):1252-1253.
    View in: PubMed
    Score: 0.227
  3. Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nocere. Dig Liver Dis. 2020 11; 52(11):1248-1249.
    View in: PubMed
    Score: 0.224
  4. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Dig Liver Dis. 2020 06; 52(6):604-605.
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.